Option chain shows key data for Mustang Bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Mustang Bio.

Mustang Bio (NASDAQ:MBIO) Stock, Option Chain

Mustang Bio

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Servicenow,Office,Building,At,Their,Headquarters,In,Santa,Clara,,California,

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACOG

ACTG

AGMH

CNEY

ENSC

GNLN

KALU

KRNY

LGCB

MBIO

RLMD

SWIM

Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

wall street christmas unsplash

Earnings

Equities

Eurozone

Commodities

AIFF

HEES

NMHI

PHIO

Dow Gains Over 200 Points; Signet Jewelers Shares Plunge

Crude-oil-4-logo

Intraday Update

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

Mustang Bio Inc

Financing

Press Releases

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

Health Care

General

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

Mustang Bio Receives Positive Listing Determination from Nasdaq

Mustang Bio Announces Reverse Stock Split

IPOs

Mustang Bio Announces Pricing of $8 Million Public Offering

Mustang Bio Announces Closing of $8 Million Public Offering

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

FBIO

Aditxt

Alzamend Neuro

Aptevo Therapeutics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Bone Biologics

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Ensysce Biosciences

Entero Therapeutics

Galecto

Genprex

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Palisade Bio

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Synaptogenix

Tharimmune

VivoSim Labs

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

HC Wainwright & Co.

Cantor Fitzgerald

BTIG

Comments

Mustang Bio

Mustang Bio (MBIO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell